These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 18624006

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B.
    Jeng WJ, Sheen IS, Liaw YF.
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):541-5. PubMed ID: 20298811
    [Abstract] [Full Text] [Related]

  • 3. Markers of disease activity in chronic hepatitis B virus infection.
    Yalcin K, Degertekin H, Yildiz F, Celik Y.
    Clin Invest Med; 2003 Feb; 26(1):27-34. PubMed ID: 12659467
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
    Kumar M, Chauhan R, Gupta N, Hissar S, Sakhuja P, Sarin SK.
    Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
    [Abstract] [Full Text] [Related]

  • 6. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
    Tseng TC, Liu CJ, Wang CC, Chen PJ, Lai MY, Chen DS, Kao JH.
    Antivir Ther; 2009 Apr; 14(2):203-10. PubMed ID: 19430095
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy.
    Giannini EG, Torre F, Basso M, Feasi M, Boni S, Grasso A, De Leo P, Dodi F, Marazzi MG, Azzola E, Bartolacci V, Percario G, Beltrame A, Borro P, Savarino V, Picciotto A, Ligurian Hepatitis B Virus Study Group.
    J Clin Gastroenterol; 2009 Apr; 43(10):1001-7. PubMed ID: 19318981
    [Abstract] [Full Text] [Related]

  • 9. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 10. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH, Na IH, Cha JM, Cho YK, Park SY, Kim HP, Song CS, Heo J, Cho M.
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [Abstract] [Full Text] [Related]

  • 11. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
    Han Y, Tang Q, Zhu W, Zhang X, You L.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
    [Abstract] [Full Text] [Related]

  • 12. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion.
    Ni YH, Chang MH, Chen PJ, Tsai KS, Hsu HY, Chen HL, Tsuei DJ, Chen DS.
    Gastroenterology; 2007 Jun; 132(7):2340-5. PubMed ID: 17570209
    [Abstract] [Full Text] [Related]

  • 13. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.
    Chu CJ, Hussain M, Lok AS.
    Hepatology; 2002 Dec; 36(6):1408-15. PubMed ID: 12447866
    [Abstract] [Full Text] [Related]

  • 14. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
    Madan K, Batra Y, Jha JK, Kumar S, Kalra N, Paul SB, Singh R, Duttagupta S, Panda SK, Acharya SK.
    Trop Gastroenterol; 2008 Dec; 29(2):84-90. PubMed ID: 18972767
    [Abstract] [Full Text] [Related]

  • 15. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL, Netherlands Association of Gastroenterologists and Hepatologists.
    Neth J Med; 2008 Dec; 66(7):292-306. PubMed ID: 18663260
    [Abstract] [Full Text] [Related]

  • 16. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [Abstract] [Full Text] [Related]

  • 17. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
    Tseng TC, Liu CJ, Wang CC, Chen PJ, Lai MY, Kao JH, Chen DS.
    Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
    [Abstract] [Full Text] [Related]

  • 18. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
    Bozkaya H, Bozdayi M, Türkyilmaz R, Sarioglu M, Cetinkaya H, Cinar K, Köse K, Yurdaydin C, Uzunalimoglu O.
    Hepatogastroenterology; 2000 Aug; 47(36):1675-9. PubMed ID: 11149030
    [Abstract] [Full Text] [Related]

  • 19. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ.
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [Abstract] [Full Text] [Related]

  • 20. Low level wild-type and pre-core mutant hepatitis B viruses and HBeAg negative reactivation of chronic hepatitis B.
    Oketani M, Oketani K, Xiaohong C, Arima T.
    J Med Virol; 1999 Aug; 58(4):332-7. PubMed ID: 10421398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.